VExUS in Ards Patients and Association with AKI (NCT06805409) | Clinical Trial Compass
RecruitingNot Applicable
VExUS in Ards Patients and Association with AKI
France120 participantsStarted 2024-12-02
Plain-language summary
A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppler and the VExUS score.
Who can participate
Age range18 Years – 100 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients ≥18 years old
* Moderate to severe ARDS according to the Berlin definition
* Requiring catecholamine support
* Undergoing invasive mechanical ventilation for less than 48 hours
Exclusion Criteria:
* Patients presenting with acute kidney injury KDIGO III requiring renal replacement therapy before the initial ultrasound evaluation
* Requirement for veno-venous or veno-arterial ECMO circulatory support before inclusion
* Patients with end-stage chronic kidney disease, on dialysis, and/or kidney transplant recipients
* History of Child C cirrhosis and/or liver transplantation and/or portal hypertension
* History of portal thrombosis
* Known history of pulmonary hypertension
* Pregnant women
* Patients under legal protection
* Patients who have expressed opposition to participating in the research
What they're measuring
1
Proportion of VExUS score ≥ 1 within 48 hours of invasive mechanical ventilation.
Timeframe: 48 hours, 7 days after mechanical ventilation